Butters, GB
Jeff Butters, Reading GB
Patent application number | Description | Published |
---|---|---|
20090048696 | DIGITAL AUDIO PROCESSING - The invention concerns digital audio processing and in particular the detection of periods where samples can be deleted or repeated unobtrusively so as to change the average sample-rate or to provide time delay modification. Differences between succeeding sample values are evaluated and compared with a threshold and samples are deleted or repeated where two or more consecutive sample value differences are less than the said threshold value. | 02-19-2009 |
20140359175 | RE-TIMING SAMPLED DATA - For re-timing sampled data, input data samples at an input data rate are stored in a FIFO buffer and output at an output data rate according to an output clock that is locked to the input data rate in dependence on a loop-filtered measure of the fill level of the said buffer. The frequency of the output clock is additionally controlled by an estimate of the input data rate. | 12-04-2014 |
20150131815 | METHOD AND APPARATUS FOR PROCESSING A SWITCHED AUDIO SIGNAL FROM A CROSSPOINT ROUTER - Apparatus is provided for processing a switched audio signal output received from a crosspoint router having a plurality of inputs and a plurality of outputs, there being a control signal that defines which of the plurality of inputs is to be routed by the crosspoint router to which of the plurality of outputs. A control unit receives the control signal and serves to identify a route change in the control signal. An instantaneous value of the switched audio signal prior to the route change is stored. A signal processing unit then combines the stored value with values of the switched audio signal after the route change to form a processed audio signal that changes smoothly. | 05-14-2015 |
20150161145 | ADJUSTING OCCUPANCIES OF A SET OF BUFFERS - The respective occupancies of a set of audio buffers are controlled via a common target occupancy value common to all the buffers in the set. This common target may take non-integral values. For each buffer, the difference is taken between the occupancy value of the buffer and the common target occupancy value. A sample is dropped or repeated as the difference exceeds half a sample. A recursive sum is formed of the fractional parts of the difference measures from the set of buffers and the recursive sum is used to adjust the common target occupancy value, within a selected range of values. | 06-11-2015 |
Jonathan Andrew Butters, Liverpool GB
Patent application number | Description | Published |
---|---|---|
20130274640 | EXERCISE AND GAIT-TRAINING APPARATUS - An exercise and gait-training, apparatus includes a framework adapted for location above a surface, a harness to support a person relative to the framework, an orthosis adapted for attachment to a lower leg or a foot of one leg of said person, a first pair of first actuators connected to the framework and to the harness whereby one side of the harness is moved to move a hip or a thigh of said one leg of said supported person relative to the framework, a second pair of first actuators connected to the framework and to the orthosis whereby the orthosis is moved relative to the framework, and a controller to control and to synchronize operation of the actuators such that the first leg is moved in a pathway simulating a natural movement of the leg during walking, a running or a sporting activity. | 10-17-2013 |
Jonathan D. Butters, Huddersfield GB
Patent application number | Description | Published |
---|---|---|
20110320186 | ENTITY RECOGNITION - The invention relates to a method of querying technical domains that recognises the concepts represented by strings of characters, rather than merely comparing strings. It can be used to compute conceptual similarity between terms. The method employs string distance metrics and a cyclic progression of lexical processing to recognise constituent term concepts that are then combined to form full-term concepts by means of a grammar. Terms can be extracted and identified as being conceptually similar (or dissimilar) to other terms even if they have never previously been encountered. | 12-29-2011 |
Martin Butters, West Yorkshire GB
Patent application number | Description | Published |
---|---|---|
20110042613 | SWELLABLE COMPOSITIONS - Water-swellable compositions, dispersions and hydrophilic cross-linked polymer microparticles for their preparation as well as their manufactures and uses are described. The polymer microparticles are formed from a monomer blend comprising sulphonic monomer, nonionic monomer and optionally other monomers and have a volume mean average size of below 20 microns. The compositions are useful in applications, such as seals and other water blocking applications. | 02-24-2011 |
Martin Peter Butters, Bradford GB
Patent application number | Description | Published |
---|---|---|
20120138275 | FOAM COMPOSITION - A foam composition comprising, A) a cellulose foam matrix, and B) particles of encapsulated organic phase change material which are distributed within the cellulose foam matrix. The invention also relates to a method for making the foam composition and also their use in thermal storage applications, such as air-conditioning units. | 06-07-2012 |
20120149265 | PARTICULATE COMPOSITION - A particulate composition comprising, A) an organic phase change material, B) a water insoluble polymeric matrix comprising, B1) polymeric material containing repeating monomer units formed from i) at least one hydrophobic ethylenically unsaturated monomer(s), and ii) at least one hydrophilic ethylenically unsaturated monomer(s) which provides the polymeric material with pendent functional groups, and, B2) a cross-linking component derived from a cross-linking compound which has reacted with said pendent functional groups of the polymeric material, in which the organic phase change material (A) is distributed as a separate phase throughout the water insoluble polymeric matrix (B). The invention also relates to a process of providing a particulate composition employing the steps, 1) providing an aqueous phase containing dissolved polymeric material which polymeric material contains repeating monomer units of i) at least one hydrophobic ethylenically unsaturated monomer(s), and ii) at least one hydrophilic ethylenically unsaturated monomer(s) which provides the polymeric material with pendent functional groups, 2) emulsifying the organic phase change material into the aqueous phase to form an oil in water emulsion comprising a dispersed phase of organic phase change material and a continuous aqueous phase, 3) introducing a cross-linking compound, 4) subjecting the oil in water emulsion to spray drying to evaporate water and form the particulate composition. The particulate composition can be used in a variety of thermal energy regulation or storage applications in for instance textiles, foamed articles, construction articles and electrical equipment. | 06-14-2012 |
20160075929 | FOAM COMPOSITION - A foam composition comprising, | 03-17-2016 |
Martin Peter Butters, West Yorkshire GB
Patent application number | Description | Published |
---|---|---|
20090029168 | Reverse Phase Hydrophilic Polymers and Their Use in Water-Expandable Elastomeric Compositions - Water-swellable compositions, dispersions and polymer microparticles for their preparation as well as their manufactures and uses are described. | 01-29-2009 |
20110121246 | HEAT STORAGE COMPOSITIONS AND THEIR MANUFACTURE - A thermal energy storage composition having improved fire retardant properties comprising: A) particles of organic phase change material (PCM), B) particles of fire retarding magnesium hydroxide and/or aluminium hydroxide, and/or C) magnesia cement, in which the particles of (A) organic phase change material are distributed uniformly throughout particles of (B) magnesium hydroxide and/or aluminium hydroxide and/or throughout (C) magnesia cement. The composition is suitable for producing a variety of articles having thermal energy storage properties and/or temperature regulation. Suitable articles include fibres, fabrics, foams, heating and cooling devices and building materials. | 05-26-2011 |
20120073226 | WALL FORM UNITS AND SYSTEMS - A wall form unit for containing a pourable, curable construction material for forming a wall section integrating said wall form unit and said construction material, comprising a first panel and a second panels spaced apart in predetermined relation thereby forming a hollow between first and second panels for defining said wall section and at least one tie assembly having a spacer member for maintaining said first and second panel in predetermined relation, in which both the first panel and second panels are rigid and adapted to retain said construction material, wherein the first panel is constructed of a thermally insulating material and the second panel is constructed of a thermally conducting material. A wall form system for forming a section of wall and wall section and method for constructing same are also defined. The invention also relates to a panel for use in forming a wall form unit and also claims a kit for constructing a wall form unit. | 03-29-2012 |
Michael Butters, Bristol GB
Patent application number | Description | Published |
---|---|---|
20080207903 | Chemical Process - A process for formation of a compound of formula (I) or a pharmaceutically acceptable salt thereof, (A chemical formula should be inserted here—please see paper copy enclosed herewith) I via a Heck reaction is described. Intermediates useful in the process and processes for making said intermediates are also described. | 08-28-2008 |
20090043097 | Methods - A method for the preparation of a compound of formula (1) or a pharmaceutically acceptable salt or solvate thereof; from a compound of the formula: (IV); wherein L represents a leaving group. | 02-12-2009 |
20100210841 | CHEMICAL PROCESS 632 - A process for preparing pharmaceutically active compounds of formula (I) or a salt thereof | 08-19-2010 |
20100217000 | Process for the Preparation of Thiazolopyrimidines - A method for the preparation of a compound of formula (1) or a pharmaceutically acceptable salt or solvate thereof; from a compound of the formula: (IV); wherein L represents a leaving group. | 08-26-2010 |
20100228028 | PROCESSES FOR THE MANUFACTURE OF ROSUVASTATIN AND INTERMEDIATES - A process for the manufacture of a compound of formula (V), useful for making rosuvastatin, by a stereoselective aldol reaction is described. Novel intermediates and processes to make them are also described. | 09-09-2010 |
20110046394 | Pharmaceutical Process and Intermediates 714 - The invention relates to compounds of formula (X), and salts thereof, and their use as intermediates in improved manufacturing processes for the synthesis of pharmaceutical compound (I): | 02-24-2011 |
Simon Butters, Dorset GB
Patent application number | Description | Published |
---|---|---|
20140043033 | APPARATUS AND METHOD FOR INSPECTING PCB-MOUNTED INTEGRATED CIRCUITS - A method and apparatus for testing the mounting of an integrated circuit on a printed circuit board using a ball grid array comprises directing an inclined laser beam from a line scan laser sensor at the integrated circuit, detecting the position of the lower edge of the integrated circuit from laser light backscattered from the integrated circuit and printed circuit board, determining through a trigonometric calculation the height of the integrated circuit above the printed circuit board following soldering of the ball grid array and comparing the height with reference data. The integrated circuit is deemed to have been successfully mounted to the printed circuit board if the height falls within a predetermined range. | 02-13-2014 |
Terence D. Butters, Oxford GB
Patent application number | Description | Published |
---|---|---|
20140303208 | PHARMACEUTICALLY ACTIVE PIPERIDINE DERIVATIVES - Compounds of formula (I): | 10-09-2014 |
Terry Butters, Oxfordshire GB
Patent application number | Description | Published |
---|---|---|
20160075651 | GLYCOLIPID INHIBITION USING IMINOSUGARS - The application provides iminosugars with a high activity and specificity for inhibiting ceramide glucosyltransferase. | 03-17-2016 |
Terry Butters, Garsington GB
Patent application number | Description | Published |
---|---|---|
20110136868 | AGENTS FOR INHIBITING OSTEOCLASTOGENESIS AND/OR OSTEOCLAST ACTIVATION - Agents, which are both ceramide glucosyltransferase inhibitors and glucosidase inhibitors, may inhibit osteoclastogenesis and/or reduce osteoclast activation and, therefore, may be useful for osteolytic activity and bone loss in subjects with conditions, such as multiple myeloma. | 06-09-2011 |
Terry D. Butters, Oxfordshire GB
Patent application number | Description | Published |
---|---|---|
20100137365 | Long chain N-alkyl compounds and oxa-derivatives thereof - Long chain N-alkyl amino and imino compounds, oxa-substituted derivatives thereof, and pharmaceutical compositions including such compounds are described. The long chain N-alkyl group is a C | 06-03-2010 |
20110184019 | Long chain N-Alkyl compounds and oxa-derivatives thereof - Long chain N-alkyl amino and imino compounds, oxa-substituted derivatives thereof, and pharmaceutical compositions including such compounds are described. The long chain N-alkyl group is a C | 07-28-2011 |
Terry D. Butters, Oxford GB
Patent application number | Description | Published |
---|---|---|
20100222383 | Iminosugars and methods of treating viral diseases - Provided are methods of treating or preventing viral infections caused by or associated with a Dengue virus using iminosugars. | 09-02-2010 |
20100222384 | Iminosugars and methods of treating arenaviral infections - Provided are methods of treating a disease or condition caused by or associated with a virus belonging to the Arenaviridae family using iminosugars, such as DNJ derivatives. | 09-02-2010 |
20100317696 | IMINOSUGARS AND METHODS OF TREATING BUNYAVIRAL AND TOGAVIRAL DISEASES - Provided are novel methods of treating and/or preventing a disease or condition caused by or associated with a virus belonging to the Bunyaviridae or Togaviridae family using iminosugars, such as DNJ derivatives. | 12-16-2010 |
20110065752 | METHODS OF TREATING ORTHOMYXOVIRAL INFECTIONS - Provided are novel iminosugars and methods of treating and/or preventing a disease or condition caused by or associated with a virus belonging to the Orthomyxoviridae family using iminosugars, such as DNJ derivatives. | 03-17-2011 |
20110065753 | METHODS OF TREATING POXVIRAL INFECTIONS - Provided are methods of treating a disease or condition caused by or associated with a virus belonging to the Poxyiridae family using iminosugars, such as DNJ derivatives. | 03-17-2011 |
20110065754 | IMINOSUGARS AND METHODS OF TREATING FILOVIRAL DISEASES - Provided are methods of treating a disease or condition caused by or associated with a virus belonging to the Filoviridae family using iminosugars, such as DNJ derivatives. | 03-17-2011 |
20130150405 | IMINOSUGARS AND METHODS OF TREATING TOGAVIRAL DISEASES - Provided are novel methods of treating and/or preventing a disease or condition caused by or associated with a virus belonging to the Togaviridae family using iminosugars, such as DNJ derivatives. | 06-13-2013 |
20130237567 | IMINOSUGARS AND METHODS OF TREATING VIRAL DISEASES - Provided are methods of treating or preventing viral infections caused by or associated with a Dengue virus using iminosugars. | 09-12-2013 |
20150224128 | IMINOSUGARS AND METHODS OF TREATING VIRAL DISEASES - Provided are methods of treating or preventing viral infections caused by or associated with a Dengue virus using iminosugars. | 08-13-2015 |
Terry Douglas Butters, Oxford GB
Patent application number | Description | Published |
---|---|---|
20130040990 | SYNTHESIS OF DGJNAc FROM D-GLUCURONOLACTONE AND USE TO INHIBIT ALPHA-N-ACETYLGALACTOSAMINIDASES - A convenient and scalable synthesis of DGJNAc ID from D-glucuronolactone in an overall yield of 20% is provided. DGJNAc is the first highly potent and specific competitive inhibitor of GalNAcases. DGJNAc ID is also a competitive inhibitor of -hexosaminidases. Synthesis and activity of L-DGJNAc IL is also shown. The use of DGJNAc as a potent and specific inhibitor of GalNAcases will allow useful investigation and treatment of a number of diseases, including Schindler Disease. | 02-14-2013 |